Toxicity | Children Age below 18 years | Young adults Age 19–25 years | Adults Age26-30 years | P value |
---|---|---|---|---|
(n = 27) | (n =78) | (n =52) | ||
Thyroidectomy, n (%) | ||||
Hypocalcemia | 5 (18.5) | 11 (14.1) | 8 (15.4) | 0.064 |
Transient | 4 (80.0) | 9 (81.8) | 7 (87.5) | |
Permanent | 1 (20.0) | 2 (18.2) | 1 (12.5) | 0.043 |
Recurrent laryngeal nerve damage | 1 (3.7) | 1 (1.3) | 1 (1.9) | 0.072 |
RAI ablation, n (%) | ||||
Acute: | 16 (59.3) | 36 (46.1) | 18 (34.6) | 0.041 |
Sialadenitis | 5 (31.3) | 12 (33.3) | 6 (33.3) | 0.071 |
Acute sickness (nausea, vomiting) | 4 (25.0) | 17 (47.2) | 10 (55.5) | 0.042 |
Neck pain | 7 (43.7) | 7 (19.5) | 2 (11.1) | 0.001 |
RAI ablation, n (%) | ||||
Late: | 2 (7.4) | 3 (3.8) | 1 (1.9) | 0.034 |
Sicca syndrome | 1 (50.0) | 3 (100) | 0 | |
Nasolacrimal duct obstruction | 1 (50.0) | 0 | 1 (100) | |
Second malignancy | 0 | 0 | 0 | |
Infertility | 0 | 0 | 0 | |
Lung fibrosis | 0 | 0 | 0 |